These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 61998)

  • 21. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ distribution of natural cytotoxicity in the rat.
    Potter MR; Moore M
    Clin Exp Immunol; 1978 Oct; 34(1):78-86. PubMed ID: 285769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of normal allogeneic lymphoid cell transfer in combination with chemotherapy on a transplantable tumor in rats.
    Yamada Y; Kawamura T; Gotohda E; Akiyama J; Hosokawa M; Kodama T; Kobayashi H
    Cancer Res; 1980 Mar; 40(3):954-8. PubMed ID: 6781744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
    Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
    Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-growth suppression in vivo: cooperation between immune lymphoid cells sensitized in vitro and nonimmune bone marrow cells.
    Alaba O; Bernstein ID
    J Immunol; 1978 Jun; 120(6):1941-6. PubMed ID: 307025
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteration of immunogenicity of xenogenized tumor cells in syngeneic rats by the immune responses to virus-associated antigens produced on immunizing cells.
    Hosokawa M; Okayasu T; Ikeda K; Katoh H; Suzuki Y; Kobayashi H
    Cancer Res; 1983 May; 43(5):2301-5. PubMed ID: 6831454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The haemopoietic and immunogenic capacities of living hybrid bone marrow cells tested in tumour allograft rejection.
    Kerckhaert JA; Hofhuis FM; Willers JM
    Immunology; 1975 Apr; 28(4):693-702. PubMed ID: 1150311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor neutralization by immune in vitro-sensitized splenocytes depends on an interaction with bone-marrow-derived cells.
    Scuderi P; Rosse C
    Int J Cancer; 1981 Feb; 27(2):213-9. PubMed ID: 7287216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation immunity of rats induced by hepatoma cells treated with heteroantibody.
    El-Asfahani AM; Maruta H; Mizuno D; Ishidate M; Hashimoto Y; Nishioka K
    Gan; 1975 Feb; 66(1):1-9. PubMed ID: 169181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous regression of syngeneic transplanted tumors in rats pretreated with the antileukemia drug busulfan.
    Sendo F; Miyake T; Fuyama S; Arai S
    J Natl Cancer Inst; 1978 Feb; 60(2):385-9. PubMed ID: 621755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.
    Fish DC; Djurickovic DB; Huebner RJ
    J Immunol; 1979 Dec; 123(6):2658-63. PubMed ID: 501086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
    Shu SY; Chou T; Rosenberg SA
    J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
    Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
    Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular cytotoxicity in tumor-bearing mice after transfer of normal or tumor-sensitized lymphoid cells.
    Fisher B; Wolmark N; Saffer EA
    J Natl Cancer Inst; 1980 Dec; 65(6):1303-5. PubMed ID: 6933275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo.
    Small M; Trainin N
    J Immunol; 1976 Jul; 117(1):292-7. PubMed ID: 932428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.